[1]
|
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article ID: 109119. https://doi.org/10.1016/j.diabres.2021.109119
|
[2]
|
Uslu, A.U., Sekin, Y., Tarhan, G., Canakcı, N., Gunduz, M. and Karagulle, M. (2017) Evaluation of Monocyte to High-Density Lipoprotein Cholesterol Ratio in the Presence and Severity of Metabolic Syndrome. Clinical and Applied Thrombosis/Hemostasis, 24, 828-833. https://doi.org/10.1177/1076029617741362
|
[3]
|
Tang, X., Tan, Y., Yang, Y., Li, M., He, X., Lu, Y., et al. (2021) Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Diabetic Retinopathy. Frontiers in Cardiovascular Medicine, 8, Article ID: 707008. https://doi.org/10.3389/fcvm.2021.707008
|
[4]
|
Kahraman, C., Kahraman, N.K. and Cosgun, S. (2016) Prognostic Value of the Monocyte/High Density Lipoprotein Cholesterol Ratio in Diabetic Nephropathy Patients. Acta Medica Mediterranea, 32, 981-985.
|
[5]
|
Onalan, E. (2019) The Relationship between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Diabetic Nephropathy. Pakistan Journal of Medical Sciences, 35, 1081-1086. https://doi.org/10.12669/pjms.35.4.534
|
[6]
|
Efe, F.K. (2021) The Association between Monocyte HDL Ratio and Albuminuria in Diabetic Nephropathy. Pakistan Journal of Medical Sciences, 37, 1128-1132. https://doi.org/10.12669/pjms.37.4.3882
|
[7]
|
Guo, K., Elzinga, S., Eid, S., Figueroa-Romero, C., Hinder, L.M., Pacut, C., et al. (2019) Genome-Wide DNA Methylation Profiling of Human Diabetic Peripheral Neuropathy in Subjects with Type 2 Diabetes Mellitus. Epigenetics, 14, 766-779. https://doi.org/10.1080/15592294.2019.1615352
|
[8]
|
Vural, G. and Gümüsyayla, Ş. (2018) Monocyte-to-High Density Lipoprotein Ratio Is Associated with a Decreased Compound Muscle Action Potential Amplitude in Patients with Diabetic Axonal Polyneuropathy. Medicine, 97, e12857. https://doi.org/10.1097/md.0000000000012857
|
[9]
|
Gökçay Canpolat, A., Emral, R., Keskin, Ç., Canlar, Ş., Şahi̇n, M. and Çorapçioğlu, D. (2019) Association of Monocyte-to-High Density Lipoprotein-Cholesterol Ratio with Peripheral Neuropathy in Patients with Type II Diabetes Mellitus. Biomarkers in Medicine, 13, 907-915. https://doi.org/10.2217/bmm-2018-0451
|
[10]
|
Schröder, S., Palinski, W. and Schmid-Schönbein, G.W. (1991) Activated Monocytes and Granulocytes, Capillary Nonperfusion, and Neovascularization in Diabetic Retinopathy. The American Journal of Pathology, 139, 81-100.
|
[11]
|
Çallı, Ü. (2022) Association of Monocyte to High-Density Lipoprotein Cholesterol Ratio with Diabetic Retinopathy in Patients with Type II Diabetes Mellitus. Bosphorus Medical Journal, 9, 173-177. https://doi.org/10.14744/bmj.2022.36036
|
[12]
|
Yalinbas Yeter, D., Eroglu, S., Sariakcali, B., Bozali, E., Vural Ozec, A. and Erdogan, H. (2021) The Usefulness of Monocyte-to-High Density Lipoprotein and Neutrophil-to-Lymphocyte Ratio in Diabetic Macular Edema Prediction and Early Anti-VEGF Treatment Response. Ocular Immunology and Inflammation, 30, 901-906. https://doi.org/10.1080/09273948.2020.1849739
|
[13]
|
Ya, G., Qiu, Z. and Tianrong, P. (2018) Relation of Monocyte/High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Type 2 Diabetes Mellitus. Clinical Laboratory, 64, 901-906. https://doi.org/10.7754/clin.lab.2018.171022
|
[14]
|
Wu, T., Zheng, Y., Chen, Y., Yu, Z., Ma, Y. and Xie, X. (2019) Monocyte to High-Density Lipoprotein Cholesterol Ratio as Long-Term Prognostic Marker in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Lipids in Health and Disease, 18, Article No. 180. https://doi.org/10.1186/s12944-019-1116-2
|
[15]
|
Li, C., Fan, H., Liu, Y., Zeng, L., Chen, P., Duan, C., et al. (2021) The Monocyte to High-Density Lipoprotein Cholesterol Ratio and Outcomes in Type 2 Diabetes Mellitus Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Annals of Translational Medicine, 9, 1627-1627. https://doi.org/10.21037/atm-21-4876
|
[16]
|
Mayasari, D.S., Taufiq, N. and Hariawan, H. (2021) Association of Monocyte-to-High Density Lipoprotein Ratio with Arterial Stiffness in Patients with Diabetes. BMC Cardiovascular Disorders, 21, Article No. 362. https://doi.org/10.1186/s12872-021-02180-6
|
[17]
|
Chen, J.W., Li, C., Liu, Z.H., Shen, Y., Ding, F.H., Shu, X.Y., et al. (2019) The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes. Frontiers in Endocrinology, 10, Article No. 191. https://doi.org/10.3389/fendo.2019.00191
|
[18]
|
Han, M.R., Ao, N., Wang, H., et al. (2021) Monocyte to High-Density Lipoprotein Ratio and Lower Extremity Atherosclerosis Disease in Patients with Type 2 Diabetes Mellitus. Chinese General Practice, 24, 663-668.
|